The COVID-19 crisis has shaken every industry, but none more so than healthcare. There is a silver lining, however: There is more interest than ever in startups in the digital health sector. Take away insights from BioEnterprise’s digital health team and regional investment professionals that can strengthen your business as the world recovers from the pandemic. This is the third session in our four-part BioEDU Business of Bioscience series, which take place every Thursday at 9:00 a.m. and feature live conversations with bioscience industry veterans. Particular emphasis will be given to concerns relevant to healthcare startups in a post-COVID environment.
- Tyler Allchin, BioEnterprise Director of Growth and Expansion
- Todd Federman, North Coast Ventures Managing Director
- Julianne Roseman, Plug & Play Cleveland Ventures Associate
- Chad Zimmerman, BioEnterprise Executive-in-Residence, Digital Health